Danimer Scientific Announces Release Date for Second Quarter 2024 Results
Danimer Scientific (NYSE: DNMR), a leading bioplastics company, has announced the release date for its second quarter 2024 financial results. The company will disclose its results after market close on Thursday, August 8, 2024, followed by a webcast and conference call at 4:30 p.m. Eastern Time on the same day. The call will include a review of Q2 results, recent events, and a Q&A session.
Investors can access the live webcast through the Investor Relations section of Danimer's website. For those unable to join the webcast, a conference call option is available by dialing 1-800-717-1738 (domestic) or 1-646-307-1865 (international). An archived version of the webcast will be available for replay on the company's website after the call.
Danimer Scientific (NYSE: DNMR), un'azienda leader nel settore dei bioplastiche, ha annunciato la data di pubblicazione dei suoi risultati finanziari del secondo trimestre 2024. L'azienda renderà noti i risultati dopo la chiusura del mercato di giovedì 8 agosto 2024, seguito da una diretta web e una teleconferenza alle 16:30 ora orientale dello stesso giorno. La teleconferenza includerà una revisione dei risultati del Q2, eventi recenti e una sessione di domande e risposte.
Gli investitori possono accedere alla diretta web tramite la sezione Relazioni con gli Investitori del sito web di Danimer. Per coloro che non possono partecipare alla diretta, è disponibile un'opzione di teleconferenza componendo il numero 1-800-717-1738 (nazionale) o 1-646-307-1865 (internazionale). Una versione registrata della diretta web sarà disponibile per la riproduzione sul sito dell'azienda dopo la teleconferenza.
Danimer Scientific (NYSE: DNMR), una empresa líder en bioplásticos, ha anunciado la fecha de publicación de sus resultados financieros del segundo trimestre de 2024. La empresa dará a conocer sus resultados después del cierre del mercado el jueves 8 de agosto de 2024, seguido de una transmisión en vivo y una llamada de conferencia a las 4:30 p.m. hora del Este ese mismo día. La llamada incluirá una revisión de los resultados del Q2, eventos recientes y una sesión de preguntas y respuestas.
Los inversores pueden acceder a la transmisión en vivo a través de la sección de Relaciones con Inversores en el sitio web de Danimer. Para aquellos que no puedan unirse a la transmisión, hay disponible una opción de llamada de conferencia marcando el 1-800-717-1738 (nacional) o el 1-646-307-1865 (internacional). Una versión grabada de la transmisión estará disponible para su reproducción en el sitio web de la empresa después de la llamada.
다니머 사이언티픽(Danimer Scientific)(NYSE: DNMR), 선도적인 생분해성 플라스틱 회사가 2024년 2분기 재무 결과 발표일을 발표했습니다. 회사는 2024년 8월 8일 목요일 장 마감 후에 결과를 공개하며, 같은 날 동부 표준시 오후 4시 30분에 웹캐스트 및 컨퍼런스 콜을 진행합니다. 이 통화에서는 2분기 실적 검토, 최근 사건에 대한 논의 및 질의응답 세션이 포함될 예정입니다.
투자자들은 다니머 웹사이트의 투자자 관계 섹션을 통해 실시간 웹캐스트에 접근할 수 있습니다. 웹캐스트에 참여할 수 없는 분들은 1-800-717-1738 (국내) 또는 1-646-307-1865 (국제)에 전화하여 컨퍼런스 콜 옵션을 이용할 수 있습니다. 통화 후 회사 웹사이트에서 웹캐스트의 기록된 버전을 재생할 수 있습니다.
Danimer Scientific (NYSE: DNMR), une entreprise leader dans le secteur des bioplastiques, a annoncé la date de publication de ses résultats financiers du deuxième trimestre 2024. L'entreprise dévoilera ses résultats après la fermeture du marché le jeudi 8 août 2024, suivie d'un webinaire et d'une conférence téléphonique à 16h30, heure de l'Est le même jour. L'appel comprendra un examen des résultats du T2, des événements récents et une session de questions-réponses.
Les investisseurs peuvent accéder au webinaire en direct via la section Relations Investisseurs du site web de Danimer. Pour ceux qui ne peuvent pas rejoindre le webinaire, une option de conférence téléphonique est disponible en composant le 1-800-717-1738 (national) ou le 1-646-307-1865 (international). Une version archivée du webinaire sera disponible en replay sur le site de l'entreprise après l'appel.
Danimer Scientific (NYSE: DNMR), ein führendes Unternehmen im Bereich Bioplastik, hat das Datum für die Veröffentlichung seiner Finanzergebnisse des zweiten Quartals 2024 bekannt gegeben. Das Unternehmen wird seine Ergebnisse nach Marktschluss am Donnerstag, den 8. August 2024, bekannt geben, gefolgt von einem Webcast und einer Telefonkonferenz um 16:30 Uhr Eastern Time am selben Tag. Der Anruf wird eine Überprüfung der Q2-Ergebnisse, aktuelle Ereignisse und eine Fragerunde umfassen.
Investoren können auf den Live-Webcast über den Bereich Investor Relations der Website von Danimer zugreifen. Für diejenigen, die nicht an der Webcast teilnehmen können, steht eine Telefonkonferenzoption zur Verfügung unter 1-800-717-1738 (inländisch) oder 1-646-307-1865 (international). Eine aufgezeichnete Version des Webcasts wird nach der Konferenz auf der Website des Unternehmens zur Verfügung stehen.
- None.
- None.
A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company’s second quarter results, discuss recent events and conduct a question and-answer session. The live webcast of the conference will be accessible on the Investor Relations section of the Company’s website at https://ir.danimerscientific.com.
For those unable to access the webcast, the conference call will be accessible domestically or internationally, by dialing 1-800-717-1738 or 1-646-307-1865, respectively. Upon dialing in, please request to join the Danimer Scientific Second Quarter 2024 Earnings Conference Call. The archived webcast will be available for replay on the Company's website after the call.
About Danimer Scientific
Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 480 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations. For more information, visit https://danimerscientific.com.
Forward‐Looking Statements
Please note that in this press release we may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the Company’s expectations for our future and operational performance. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this release include, but are not limited to, the overall level of consumer demand on our products; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital, and credit markets; the financial strength of the Company's customers; the Company's ability to implement its business strategy, including, but not limited to, its ability to expand its production facilities and plants to meet customer demand for its products and the timing thereof; risks relating to the uncertainty of the projected financial information with respect to the Company; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to our products; the Company’s exposure to product liability or product warranty claims and other loss contingencies; the impact on our business, operations and financial results from the ongoing conflict in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240802405922/en/
Investors and Media
Blake
Phone: 770-337-6570
ir@danimer.com
Source: Danimer Scientific, Inc.
FAQ
When will Danimer Scientific (DNMR) release its Q2 2024 financial results?
How can investors access Danimer Scientific's (DNMR) Q2 2024 earnings call?
What will be discussed in Danimer Scientific's (DNMR) Q2 2024 earnings call?